Ni Y, Zhang Y, Zheng L, et al
Some other candidates in development with long half-lives include Zealand Pharma/Roches Petrelintide (amylin analog), QL Biopharms ZT-002 (GLP-1 RA), and Amgens MariTide (GLP-1 RA/GIP antagonist)
If you're ready to see the difference that quality and care can make, you can Get Started Today
Medications such as liraglutide, semaglutide, and dulaglutide are based on human GLP-1 rather than exendin-4
Families should expect GI side effects during escalation and understand that continued behavioral treatment alongside pharmacotherapy produces better outcomes than medication alone
Zepbound is ideal for patients who: Want a more aggressive weight-loss option Struggle with metabolic resistance Have tried other treatments but hit plateaus How Wegovy and Zepbound Compare Similarities Both medications: Are FDA-approved for chronic weight management Are given once weekly Improve metabolic function and insulin sensitivity Reduce appetite and cravings Are appropriate for patients with a BMI over 30, or over 27 with weight-related conditions Both are also considered safe when monitored by a qualified medical provider, which is essential to avoid improper dosing and prevent side effects
